S. Johnston and M. Dowsett, Aromatase inhibitors for breast cancer: lessons from the laboratory, Nature Reviews Cancer, vol.3, issue.11, pp.821-852, 2003.
DOI : 10.1038/nrc1211

C. Thomas and J. Gustafsson, The different roles of ER subtypes in cancer biology and therapy, Nature Reviews Cancer, vol.107, issue.8, pp.597-608, 2011.
DOI : 10.1073/pnas.1002029107

C. Thomas and J. Gustafsson, Progesterone receptor-estrogen receptor crosstalk: a novel insight, Trends in Endocrinology & Metabolism, vol.26, issue.9, pp.453-457, 2015.
DOI : 10.1016/j.tem.2015.08.002

M. Rodríguez-paredes and M. Esteller, Cancer epigenetics reaches mainstream oncology, Nature Medicine, vol.18, issue.3, pp.330-339, 2011.
DOI : 10.1038/sj.leu.2403388

M. Dawson and T. Kouzarides, Cancer Epigenetics: From Mechanism to Therapy, Cell, vol.150, issue.1, pp.12-27, 2012.
DOI : 10.1016/j.cell.2012.06.013

URL : https://doi.org/10.1016/j.cell.2012.06.013

K. Jozwik and J. Carroll, Pioneer factors in hormone-dependent cancers, Nature Reviews Cancer, vol.100, issue.6, pp.381-386, 2012.
DOI : 10.1073/pnas.0932692100

C. Ross-innes, R. Stark, A. Teschendorff, K. Holmes, H. Ali et al., Differential oestrogen receptor binding is associated with clinical outcome in breast cancer, Nature, vol.2, issue.7381, pp.389-93, 2012.
DOI : 10.1371/journal.pbio.0020108

URL : http://europepmc.org/articles/pmc3272464?pdf=render

C. Plass, S. Pfister, A. Lindroth, O. Bogatyrova, C. R. Lichter et al., Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer, Nature Reviews Genetics, vol.52, issue.11, pp.765-80, 2013.
DOI : 10.1038/nprot.2011.402

C. Curtis, S. Shah, S. Chin, G. Turashvili, O. Rueda et al., The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, issue.7403, pp.346-52, 2012.
DOI : 10.1038/nature06757

URL : http://europepmc.org/articles/pmc3440846?pdf=render

K. Jozwik, I. Chernukhin, A. Serandour, S. Nagarajan, and J. Carroll, FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3, Cell Reports, vol.17, issue.10, pp.2715-2738, 2016.
DOI : 10.1016/j.celrep.2016.11.028

URL : https://doi.org/10.1016/j.celrep.2016.11.028

A. Serandour, S. Avner, F. Percevault, F. Demay, M. Bizot et al., Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers, Genome Research, vol.21, issue.4, pp.555-65, 2011.
DOI : 10.1101/gr.111534.110

URL : https://hal.archives-ouvertes.fr/hal-00587841

B. Belandia, R. Orford, H. Hurst, and M. Parker, Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes, The EMBO Journal, vol.21, issue.15, pp.4094-103, 2002.
DOI : 10.1093/emboj/cdf412

J. Direnzo, Y. Shang, M. Phelan, S. Sif, M. Myers et al., BRG-1 Is Recruited to Estrogen-Responsive Promoters and Cooperates with Factors Involved in Histone Acetylation, Molecular and Cellular Biology, vol.20, issue.20, pp.7541-7550, 2000.
DOI : 10.1128/MCB.20.20.7541-7549.2000

A. Hohmann and C. Vakoc, A rationale to target the SWI/SNF complex for cancer therapy, Trends in Genetics, vol.30, issue.8, pp.356-63, 2014.
DOI : 10.1016/j.tig.2014.05.001

URL : http://europepmc.org/articles/pmc4112150?pdf=render

K. Helin and D. Dhanak, Chromatin proteins and modifications as drug targets, Nature, vol.31, issue.7472, pp.480-488, 2013.
DOI : 10.1038/ncb1546

URL : https://curis.ku.dk/ws/files/131788035/Helin_Dhanak_final.pdf

N. Fortunati, S. Bertino, L. Costantino, D. Bortoli, M. Compagnone et al., Valproic acid restores ER?? and antiestrogen sensitivity to ER??-negative breast cancer cells, Molecular and Cellular Endocrinology, vol.314, issue.1, pp.17-22, 2010.
DOI : 10.1016/j.mce.2009.09.011

P. Alluri, I. Asangani, and A. Chinnaiyan, BETs abet Tam-R in ER-positive breast cancer, Cell Research, vol.153, issue.8, pp.899-900, 2014.
DOI : 10.1016/j.cell.2013.03.036

URL : http://www.nature.com/cr/journal/v24/n8/pdf/cr201490a.pdf

B. Ladd, A. Mazzola, T. Bihani, Z. Lai, J. Bradford et al., Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations, Oncotarget, vol.7, issue.34, pp.54120-54156, 2016.
DOI : 10.18632/oncotarget.10852

URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=10852&path%5B%5D=34354

S. Shu, C. Lin, H. He, R. Witwicki, D. Tabassum et al., Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer, Nature, vol.56, issue.7586, pp.413-420, 2016.
DOI : 10.1016/j.molcel.2014.08.024

URL : http://europepmc.org/articles/pmc4854653?pdf=render

H. Mohammed, D. Santos, C. Serandour, A. Ali, H. Brown et al., Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor, Cell Reports, vol.3, issue.2, pp.342-351, 2013.
DOI : 10.1016/j.celrep.2013.01.010

URL : https://doi.org/10.1016/j.celrep.2013.01.010

K. Mulder, X. Wang, C. Escriu, Y. Ito, R. Schwarz et al., Diverse epigenetic strategies interact to control epidermal differentiation, Nature Cell Biology, vol.39, issue.7, pp.753-63, 2012.
DOI : 10.1016/j.ymeth.2009.03.001

H. Kawai, H. Li, P. Chun, S. Avraham, and H. Avraham, Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells, Oncogene, vol.21, issue.50, pp.7730-7739, 2002.
DOI : 10.1073/pnas.171174298

URL : http://www.nature.com/onc/journal/v21/n50/pdf/1205971a.pdf

S. Nagarajan, T. Hossan, M. Alawi, Z. Najafova, D. Indenbirken et al., Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription, Cell Reports, vol.8, issue.2, pp.460-469, 2014.
DOI : 10.1016/j.celrep.2014.06.016

URL : https://doi.org/10.1016/j.celrep.2014.06.016

E. Toska, H. Osmanbeyoglu, P. Castel, C. Chan, R. Hendrickson et al., PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D, Science, vol.23, issue.6331, pp.1324-1354, 2017.
DOI : 10.1093/nar/gku365

URL : http://europepmc.org/articles/pmc5485411?pdf=render

H. Mohammed, C. Taylor, G. Brown, E. Papachristou, J. Carroll et al., Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes, Nature Protocols, vol.691, issue.2, pp.316-342, 2016.
DOI : 10.1016/j.cell.2005.08.020

V. Theodorou, R. Stark, S. Menon, and J. Carroll, GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility, Genome Research, vol.23, issue.1, pp.12-22, 2013.
DOI : 10.1101/gr.139469.112

URL : http://genome.cshlp.org/content/23/1/12.full.pdf

J. Eeckhoute, E. Keeton, M. Lupien, S. Krum, J. Carroll et al., Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor ?? Expression in Breast Cancer, Cancer Research, vol.67, issue.13, pp.6477-83, 2007.
DOI : 10.1158/0008-5472.CAN-07-0746

URL : http://cancerres.aacrjournals.org/content/canres/67/13/6477.full.pdf

J. Perdomo and M. Crossley, The Ikaros family protein Eos associates with C-terminal-binding protein corepressors, European Journal of Biochemistry, vol.277, issue.23, pp.5885-92, 2002.
DOI : 10.1074/jbc.M202079200

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1432-1033.2002.03313.x/pdf

L. Wu, Y. Wang, Y. Liu, S. Yu, H. Xie et al., A central role for TRPS1 in the control of cell cycle and cancer development, Oncotarget, vol.5, issue.17, pp.7677-90, 2014.
DOI : 10.18632/oncotarget.2291

J. Chen, Y. Bao, J. Litton, X. L. Zhang, H. Warneke et al., Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer, Hormones and Cancer, vol.133, issue.2, pp.132-175, 2011.
DOI : 10.1016/j.cell.2008.03.027

F. Sanchez-garcia, P. Villagrasa, J. Matsui, D. Kotliar, V. Castro et al., Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers, Cell, vol.159, issue.6, pp.1461-75, 2014.
DOI : 10.1016/j.cell.2014.10.048

URL : https://doi.org/10.1016/j.cell.2014.10.048

A. Hurtado, K. Holmes, C. Ross-innes, D. Schmidt, and J. Carroll, FOXA1 is a key determinant of estrogen receptor function and endocrine response, Nature Genetics, vol.14, issue.1, pp.27-33, 2011.
DOI : 10.1016/j.cell.2006.05.052

URL : http://europepmc.org/articles/pmc3024537?pdf=render

I. Kurihara, D. Lee, F. Petit, J. Jeong, K. Lee et al., COUP-TFII Mediates Progesterone Regulation of Uterine Implantation by Controlling ER Activity, PLoS Genetics, vol.251, issue.6, p.102, 2007.
DOI : 0002-9513(1986)251[E630:ASEMFS]2.0.CO;2

URL : http://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.0030102&type=printable

Y. Zhang, T. Liu, C. Meyer, J. Eeckhoute, D. Johnson et al., Model-based Analysis of ChIP-Seq (MACS), Genome Biology, vol.9, issue.9, p.137, 2008.
DOI : 10.1186/gb-2008-9-9-r137

URL : https://genomebiology.biomedcentral.com/track/pdf/10.1186/gb-2008-9-9-r137?site=genomebiology.biomedcentral.com

V. Perissi, K. Jepsen, C. Glass, and M. Rosenfeld, Deconstructing repression: evolving models of co-repressor action, Nature Reviews Genetics, vol.26, issue.2, pp.109-132, 2010.
DOI : 10.1016/j.bbagrm.2009.05.007

A. Cerase, G. Pintacuda, A. Tattermusch, and P. Avner, Xist localization and function: new insights from multiple levels, Genome Biology, vol.141, issue.1, p.166, 2015.
DOI : 10.1016/j.cell.2010.04.042

URL : https://genomebiology.biomedcentral.com/track/pdf/10.1186/s13059-015-0733-y?site=genomebiology.biomedcentral.com

A. A. Serandour,

D. Schmidt, M. Wilson, C. Spyrou, G. Brown, J. Hadfield et al., ChIP-seq: Using high-throughput sequencing to discover protein???DNA interactions, Methods, vol.48, issue.3, pp.240-248, 2009.
DOI : 10.1016/j.ymeth.2009.03.001

URL : http://europepmc.org/articles/pmc4052679?pdf=render

C. Ross-innes, R. Stark, K. Holmes, D. Schmidt, C. Spyrou et al., Cooperative interaction between retinoic acid receptor-?? and estrogen receptor in breast cancer, Genes & Development, vol.24, issue.2, pp.171-82, 2010.
DOI : 10.1101/gad.552910

URL : http://genesdev.cshlp.org/content/24/2/171.full.pdf

S. Wang, H. Sun, J. Ma, C. Zang, C. Wang et al., Target analysis by integration of transcriptome and ChIP-seq data with BETA, Nature Protocols, vol.786, issue.12, pp.2502-2515, 2013.
DOI : 10.1038/ng1901